Article
Pathogenic mutations and rare variants of the APC gene identified in 75 Belgian patients with familial adenomatous polyposis by fluorescent enzymatic mutation detection (EMD).
European journal of human genetics : EJHG - 1 Sept 2002
Michils Geneviève, Tejpar Sabine, Fryns Jean-Pierre, Legius Eric, Van Cutsem Eric, Cassiman Jean-Jacques, Matthijs Gert
Abstract excerpt
Familial adenomatous polyposis (FAP) is a dominant inherited colorectal cancer syndrome which is caused by germline mutations in the adenomatous polyposis coli (APC) gene. Enzymatic mutation detection (EMD) has potential advantages over the standard protein truncation test (PTT) that is currently used in screening the APC gene for mutations. First we wanted to validate the EMD technique in comparison to PTT....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
